Article PDF
Avoid common mistakes on your manuscript.
References
I. D. Adler, in:Chemical Mutagenesis in Mammals and Man (Eds. Vogel and Röhrborn; Springer Berlin-Heidelberg-New York 1970), p. 383.
I. D. Adler, G. Generoso andS. S. Epstein, Mutation Res.13, 263 (1971).
I. D. Adler andG. Röhrborn, Humangenetik8, 81 (1969).
S. Armendares, F. Salamanca andS. Frenk, Nature232, 271 (1971).
D. E. Bailey, K. Morgareidge, G. E. Cox, E. E. Vogin andB. L. Oser, 11th Ann. Meet. Soc. Toxicol. Williamsburg, 5–9 March 1972.
H. D. Bartsch, in:Chemical Mutagenesis in Mammals and Man (Eds. Vogel and Röhrborn; Springer Berlin-Heidelberg-New York 1970), p. 420.
M. Bauchinger, M. Pieper andN. Zöllner, Dt. med. Wschr.95, 2220 (1970).
M. Bauchinger andE. Schmid, Z. Krebsforsch.72, 77 (1969).
a. Bauer andH. Frohberg, unpublished (1972).
R. Bierling, personal communication (1972).
N. Brock, Arzneimittel-Forsch.8, 1 (1958).
B. M. Cattanach, Z. Vererbungsl.93, 215 (1962).
P. E. Conen, Lancet2, 47 (1961).
P. E. Conen, A. G. Bell andN. Aspin, Pediatrics31, 72 (1963).
W. M. Court Brown, in: Human Population Cytogenetics (North-Holland Publ. Co., Amsterdam 1967).
P. K. Datta andE. Schleiermacher, Mutation Res.8, 623 (1969).
M. v. Eberstein andH. Frohberg, unpublished (1972).
U. H. Ehling, R. B. Cumming andH. V. Malling, Mutation Res.5, 417 (1968).
H. J. Evans, in:Human Population Cytogenetics (Eds. P. A. Jacobs, W. H. Price and P. Law; Williams and Wilkins, Baltimore 1970), p. 191.
H. Frohberg, Münch. med. Wschr.112, 1532 (1970).
H. Frohberg andA. Bauer, Arzneimittel-Forsch.23, 230 (1973).
U. Gripenberg, Hereditas54, 1 (1965).
K. E. Hampel, Int. J. clin. Pharmac.1, 322 (1968).
G. Hartwich, G. Schwanitz, Dt. med. Wschr.97, 45 (1972).
P. A. Jacobs, W. M. C. Brown andR. Doll, Nature, Lond.191, 1178 (1961).
M. K. Jensen andP. Philip, Mutation Res.12, 91 (1971).
K. Karrer andO. Boeckl, Arzneimittel-Forsch.13, 605 (1963).
R. Kato, M. Bruze andY. Tegner, Hereditas61, 1 (1969).
B. Matter andW. Schmid, Mutation Res.12, 417 (1971).
D. Müller, M. Langauer, R. Rathenberg, F. F. Strasser andR. Hess, Verh. dt. Ges. Path.56, 381 (1972).
D. Müller andF. F. Strasser, Mutation Res.13, 377 (1971).
H. Oettel andG. Wilhelm, Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.230, 559 (1957).
G. Röhrborn, A. Herwig, P. Propping andW. Buselmaier, 2nd Ann. Meet. Europ. Environm. Mutagen Soc., Zinkovy Castle, Pilsen, 10–12 May 1972.
W. Schmid, D. T. Arakaki, N. A. Breslau andJ. C. Culbertson, Humangenetik11, 103 (1971).
W. Schmid andG. R. Staiger, Mutation Res.7, 99 (1969).
J. S. S. Stewart andA. R. Sanderson, Lancet1, 978 (1961).
M. J. Thorburn, S. Hutchinson andG. A. O. Alleyne, Lancet1, 591 (1972).
I. M. Tough, K. E. Buckton andA. G. Bakie, Lancet2, 949 (1960).
C. S. Weil, M. D. Woodside, J. B. Bernard, N. I. Condra andC. P. Carpenter, 11th Ann. Meet. Soc. Toxicol. Williamsburg, 5–9 March 1972.
A. G. Wheeler, D. Dansby, H. C. Hawkins, H. G. Payne andJ. H. Weikel, Jr.., Toxic. appl. Pharmac.4, 324 (1962).
WHO,Evaluation and Testing of Drugs for Mutagenicity: Principles and Problems, Tech. Rep. Ser., No. 482 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frohberg, H. Critique of in vivo cytogenetic test systems. Agents and Actions 3, 119–123 (1973). https://doi.org/10.1007/BF01986545
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01986545